Scoop has an Ethical Paywall
LSN Relaxed About GE-Ad Appeal
LSN Media Release:
LSN relaxed about GE-Ad appeal
October 29, 2002
The Life Sciences Network welcomes the opportunity to once again debate the L-Tryptophan issue in a formal environment, said Chairman of the Life Sciences Network Dr William Rolleston today.
Dr Rolleston was responding to a statement by Anti-GE campaigner Claire Bleakley.
Ms Bleakley has said she will appeal a decision by the Advertising Standards Authority to reject her complaint against an advertisement by LSN.
The full-page advertisement, which ran in newspapers in July, stated, "no health issue involving GE products has ever been substantiated".
Ms Bleakley objected to the Advertising Standards Authority saying that a GE health supplement L-Tryptophan killed 36 people and injured 1500 in 1989.
However, Dr Rolleston said, “There is no substantiated evidence that genetically modified products have posed a health problem anywhere in the world”
“The network welcomes the opportunity to once again debate the L-Tryptophan issue in a formal environment”
“We are confident any appeal authority will reconfirm what has already determined by United States courts and reported by the New Zealand Royal Commission on GE.
“The US courts found the manufacturing process rather than genetic modification was at fault in the L-Tryptophan incident in 1989”
Business Canterbury: Urges Council To Cut Costs, Not Ambition For City
Wellington Airport: On Track For Net Zero Emissions By 2028
Landcare Research: ANZAC Gall Fly Release Promises Natural Solution To Weed Threat
NZ Anti-Vivisection Society: Auckland Rat Lovers Unite!
University of Canterbury: $1.35 Million Grant To Study Lion-like Jumping Spiders
Federated Farmers: Government Ends War On Farming
